Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 2 Vaso-Occlusive Crises 1 Seaweed Associated Changes in Healthy Subjects 1 Prostatic Neoplasms 1 Proctitis 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Polyps 1 Anovulation 1 Anemia, Sickle Cell 1

Interventions

Irinotecan 4 Octreotide 3 Probiotics 2 Leucovorin 2 Fluorouracil 2 shosaiko-to 1 maltodextrin 1 lanreotide 1 isatuximab 1 bile acid binding proteins 1 Temozolomide 1 Sulfasalazine 1 Raloxifene Hydrochloride 1 Radiation 1 Oxaliplatin 1 Loperamide 1 Long-Term Synaptic Depression 1 Levofloxacin 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Diet Therapy 1 Cyclophosphamide 1 Colesevelam Hydrochloride 1 Celecoxib 1 Cefpodoxime 1 Cefixime 1 Calcium Aluminosilicate 1 Anti-Bacterial Agents 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Diarrhea × maltodextrin × Clear all

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

S&D Pharma SK s.r.o.

Phase 3 Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡